ACQUISITION OF NON-CATALOGED MEDICINES GROUP C (CARDIOVASCULAR SYSTEM CARDIAC THERAPY) FIRST QUARTER - 2025 PROGRAMMING.- PHARMACY AND THERAPEUTICS COMMITTEE MINUTES 002 – 2025

This tender concerns the acquisition of non-cataloged medicines within Group C, specifically focusing on treatments for the Cardiovascular System and Cardiac Therapy. The procurement is scheduled for the first quarter of 2025, as part of the annual programming. The contracting entity is the CENTRO CLINICO QUIRURGICO AMBULATORIO HOSPITAL DEL DIA "MARIA ROSA PARRA ARREAGA" (CCQA-HD SAMBORONDON), identified by process code SIE-CCQAHDSAMBORONDON-2025-0016-1241290. The procurement method specified is Electronic Reverse Auction. The tender includes a specific item: Amiodarone, oral solid form, 200 mg, packaged in blister/strip boxes. The required quantity for this item is 2000 units, with an estimated value of USD 440,439.85. This procurement is a crucial part of the hospital's efforts to ensure the availability of essential medications for cardiovascular treatments during the initial period of 2025, as determined by the Pharmacy and Therapeutics Committee's minutes (Acta 002 – 2025). The electronic reverse auction modality suggests a competitive bidding process where suppliers will have the opportunity to offer their best prices electronically to secure the contract for supplying these vital cardiac medications.

This is a supplies contract in the governance and public administration sector. Located in Ecuador, Latin America, this opportunity is open to firms and consortiums, with an estimated budget of USD 440,440.

Published through SERCOP Ecuador, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the governance and public administration sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.